Is there a clinical difference in outcomes when beta-agonist therapy is delivered through metered-dose inhaler (MDI) with a spacing device compared with standard nebulizer treatments in acutely wheezing children?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)760-761
Number of pages2
JournalThe Journal of family practice
Issue number8
StatePublished - Jan 1 2000

All Science Journal Classification (ASJC) codes

  • Family Practice

Cite this